Aaron Burshtein

ORCID: 0000-0003-0235-3099
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Myofascial pain diagnosis and treatment
  • Musculoskeletal pain and rehabilitation
  • Cutaneous Melanoma Detection and Management
  • Pain Management and Treatment
  • Nonmelanoma Skin Cancer Studies
  • Orthopedic Infections and Treatments
  • Clinical Reasoning and Diagnostic Skills
  • Restless Legs Syndrome Research
  • Intracerebral and Subarachnoid Hemorrhage Research
  • Hidradenitis Suppurativa and Treatments
  • Problem and Project Based Learning
  • Esophageal and GI Pathology
  • Breast Implant and Reconstruction
  • Hospital Admissions and Outcomes
  • Bacterial Infections and Vaccines
  • Innovations in Medical Education
  • Colorectal and Anal Carcinomas
  • Cannabis and Cannabinoid Research
  • Migraine and Headache Studies
  • Prenatal Substance Exposure Effects
  • Acute Ischemic Stroke Management
  • Moyamoya disease diagnosis and treatment
  • Neurological Complications and Syndromes
  • Transcranial Magnetic Stimulation Studies
  • Genital Health and Disease

Icahn School of Medicine at Mount Sinai
2023-2025

Neurology, Inc
2025

Northwell Health
2019-2024

Donald & Barbara Zucker School of Medicine at Hofstra/Northwell
2019-2024

Mount Sinai Medical Center
2024

Hofstra University
2020

New York Hospital Queens
2018

Presbyterian Hospital
2018

Weill Cornell Medicine
2018

NewYork–Presbyterian Hospital
2018

Chronic pain is a debilitating, multifactorial condition. The purpose of this study was to examine patient characteristics those who did not show up for their scheduled first medicine appointment in order identify factors that may improve access care. This retrospective analysis 810 patients from single-center academic management clinic between January 1, 2022, and December 31, 2023. Overall no-show rate 57%. There mean 133 days (4.3 months) scheduling the date. Patients age ≤ 30 years had...

10.1111/papr.70003 article EN Pain Practice 2025-01-18

Abstract Posterior reversible encephalopathy syndrome (PRES) is a disorder of cerebrovascular dysregulation. To our knowledge, we present the first case lenalidomide‐induced PRES in English. A 59‐year‐old woman with history multiple myeloma status post stem cell transplant and induction triple therapy 6 months ago partial remission subsequent high‐dose melphalan 1 month presented progressive vision loss for week. Her systolic blood pressure was >180 mmHg, neurological examination...

10.1111/ncn3.12814 article EN Neurology and Clinical Neuroscience 2024-04-12

More than 100,000 reduction mammaplasties are performed in the United States each year. There is large variance reported incidence of cancerous/high-risk lesions, ranging from 0.06% to 4.6%. has been debate whether histological review breast specimen necessary. This study aimed determine lesions and evaluate risk factors for their occurrence.A retrospective was conducted all patients who underwent mammaplasty 2018 by senior author. Variables collected included demographics, comorbidities,...

10.1097/gox.0000000000003256 article EN cc-by-nc-nd Plastic & Reconstructive Surgery Global Open 2020-11-01

Background: Hidradenitis suppurativa (HS) is a chronic, relapsing, and painful inflammatory condition of the skin. Pain in HS one most common symptoms has devastating effect on quality life. Here, we present unique case patient with pain management guidelines used to treat her condition. Case Report: This 42-year-old woman history HS, hypertension, depression who presented month groin crease, vulva, rectum. She was recently discharged from hospital for superinfection. treated intravenous...

10.25251/skin.8.4.7 article EN cc-by SKIN The Journal of Cutaneous Medicine 2024-07-23

<b><i>Objectives:</i></b> The role of aortic angulation in attenuating procedural success balloon-expandable (BE) and self-expandable (SE) transcatheter valve replacement (TAVR) has been controversial. <b><i>Methods:</i></b> We retrospectively assessed patients undergoing SE BE TAVR who had an angle measured on multidetector computed tomography at a single tertiary referral center. primary outcome was device success, per the Valve Academic...

10.1159/000488933 article EN Cardiology 2018-01-01

Background: The “drip and ship” protocol is an important treatment for acute ischemic stroke patients who do not have immediate access to comprehensive centers (CSC). Intravenous thrombolysis initiated at a primary center followed by expeditious transfer CSC typically during the tPA infusion. National guidelines recommend attention blood pressure control (<180/105 mmHg) after administration first 24 hours. We sought determine frequency of BP violations impact on patient outcomes. Methods:...

10.1161/str.46.suppl_1.tp209 article EN Stroke 2015-02-01

Knowledge surrounding inpatient costs of bacterial meningitis (BM) management is limited. We explored the financial burden BM hospitalization, including cost trends and factors associated with higher costs. Cross-sectional, retrospective analysis in publicly available database from 2014-2020. 292 patients were hospitalized for BM. Majority admissions age 18-64 (63%). Most admitted emergently vs. urgently (70.2 26.4%). LOS 0-7 days (61%) was most prevalent. Inpatient mortality rate 4.45%....

10.2139/ssrn.4460098 preprint EN 2023-01-01
Coming Soon ...